Bolt Biotherapeutics, Inc. is a pioneering clinical-stage immuno-oncology company headquartered in Redwood City, California, dedicated to revolutionizing cancer treatment through innovative approaches that leverage the immune system. Utilizing its proprietary technology platform, the company is advancing a promising pipeline of novel drug candidates aimed at augmenting tumor-specific immune responses. Bolt's strategic focus on addressing critical unmet medical needs in oncology positions it as a leader in precision oncology, with the potential to significantly enhance patient outcomes in the rapidly evolving field of cancer immunotherapy. Show more

Location: 900 CHESAPEAKE DRIVE, REDWOOD CITY, CA, UNITED STATES, 94063, Redwood City, CA, 94063, USA | Website: https://www.boltbio.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

11.32M

52 Wk Range

$4.41 - $10.50

Previous Close

$6.25

Open

$6.31

Volume

31,361

Day Range

$5.86 - $6.38

Enterprise Value

3.676M

Cash

17.75M

Avg Qtr Burn

-9.732M

Insider Ownership

6.65%

Institutional Own.

39.04%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
BDC-4182 Details Cancer, Gastric cancer	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
BDC-3042 Details Advanced cancers	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
BDC-1001 +/- pertuzumab Details HER2-expressing cancers	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.